Michael S. Weiss
2017 - TG Therapeutics
In 2017, Michael S. Weiss earned a total compensation of $9.9M as Chief Executive Officer and President at TG Therapeutics, a 156% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,969 |
|---|---|
| Salary | $525,000 |
| Stock Awards | $9,183,647 |
| Total | $9,926,616 |
Weiss received $9.2M in stock awards, accounting for 93% of the total pay in 2017.
Weiss also received $218K in non-equity incentive plan and $525K in salary.
Rankings
In 2017, Michael S. Weiss' compensation ranked 651st out of 14,666 executives tracked by ExecPay. In other words, Weiss earned more than 95.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 651 out of 14,666 | 96th |
Division Manufacturing | 215 out of 5,770 | 96th |
Major group Chemicals And Allied Products | 53 out of 2,074 | 97th |
Industry group Drugs | 37 out of 1,730 | 98th |
Industry Pharmaceutical Preparations | 32 out of 1,329 | 98th |
Source: SEC filing on April 30, 2018.
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2017.
2017
Sean Power
TG Therapeutics